Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control · 2018
[Investigation on Toxoplasma gondii infection in liver disease patients in Hangzhou City].
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jian-Feng Huang, Jian-Ping Xia, Ru-Jin Xu, Chun-Yan Qian
Аннотация
OBJECTIVE: To understand the Toxoplasma gondii infection in liver disease patients in Hangzhou City.
METHODS: A total of 1 200 patients with liver diseases were enrolled, including 300 patients with liver cancer, 300 cases with hepatitis B, 300 cases with hepatic fibrosis and 300 cases with fatty degeneration of the liver, while 1 200 healthy people served as controls. The serum anti-T. gondii IgG and IgM antibodies were detected in the subjects using ELISA assay.
RESULTS: The seropositive rates of anti-T. gondii IgG and IgM antibodies were 24.00% (288/1 200) and 1.17% (14/1 200) in the liver disease patients, and 11.42% (137/1 200) and 1.08% (13/1 200) in the healthy controls, respectively. There was a significant difference in the seropositive rate of anti-T. gondii IgG antibody between the liver disease patients and controls (χ2 = 65.19, P < 0.01), and no significant difference was seen in the seropositive rate of anti-T. gondii IgM antibody between the liver disease patients and controls (χ2 = 0.04, P > 0.05). The seropositive rates of anti-T. gondii IgG antibody were 26.00%, 25.00%, 23.33% and 21.67% in the patients with liver cancer, hepatitis B, hepatic fibrosis and fatty degeneration of the liver, respectively, and no significant difference was detected among these patients with four types of liver diseases (χ2 = 1.79, P > 0.05).
CONCLUSIONS: The seropositive rate of anti-T. gondii IgG antibody is high in liver disease patients in Hangzhou City, and the management and health education of toxoplasmosis should be given to patients with liver diseases.
METHODS: A total of 1 200 patients with liver diseases were enrolled, including 300 patients with liver cancer, 300 cases with hepatitis B, 300 cases with hepatic fibrosis and 300 cases with fatty degeneration of the liver, while 1 200 healthy people served as controls. The serum anti-T. gondii IgG and IgM antibodies were detected in the subjects using ELISA assay.
RESULTS: The seropositive rates of anti-T. gondii IgG and IgM antibodies were 24.00% (288/1 200) and 1.17% (14/1 200) in the liver disease patients, and 11.42% (137/1 200) and 1.08% (13/1 200) in the healthy controls, respectively. There was a significant difference in the seropositive rate of anti-T. gondii IgG antibody between the liver disease patients and controls (χ2 = 65.19, P < 0.01), and no significant difference was seen in the seropositive rate of anti-T. gondii IgM antibody between the liver disease patients and controls (χ2 = 0.04, P > 0.05). The seropositive rates of anti-T. gondii IgG antibody were 26.00%, 25.00%, 23.33% and 21.67% in the patients with liver cancer, hepatitis B, hepatic fibrosis and fatty degeneration of the liver, respectively, and no significant difference was detected among these patients with four types of liver diseases (χ2 = 1.79, P > 0.05).
CONCLUSIONS: The seropositive rate of anti-T. gondii IgG antibody is high in liver disease patients in Hangzhou City, and the management and health education of toxoplasmosis should be given to patients with liver diseases.